Jefferies Financial Group Inc. bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 8,327 shares of the conglomerate’s stock, valued at approximately $1,586,000.
Other institutional investors also recently modified their holdings of the company. High Note Wealth LLC raised its holdings in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after acquiring an additional 47 shares during the period. First Command Advisory Services Inc. increased its stake in shares of Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after acquiring an additional 47 shares during the last quarter. GW&K Investment Management LLC raised its holdings in shares of Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after acquiring an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC raised its stake in shares of Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after purchasing an additional 48 shares in the last quarter. Finally, Gabelli Funds LLC increased its holdings in Danaher by 0.3% in the fourth quarter. Gabelli Funds LLC now owns 18,981 shares of the conglomerate’s stock worth $4,345,000 after buying an additional 50 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have commented on DHR shares. Evercore reissued an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. DZ Bank started coverage on Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective on the stock. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. HSBC reduced their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $228.91.
Danaher Stock Up 0.3%
NYSE DHR opened at $216.41 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market cap of $152.13 billion, a PE ratio of 38.44, a PEG ratio of 2.69 and a beta of 0.78. The firm has a 50-day simple moving average of $199.46 and a 200 day simple moving average of $192.52. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the prior year, the firm posted $0.77 EPS. The company’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
